Real-world use of ofatumumab to treat multiple sclerosis 9 months post-FDA approval during COVID-19 pandemic

Autor: Coyle, Patricia K., Gorritz, Magdaliz, Wade, Rolin L., Zhou, Zifan, Khalid, Subhan, Maiese, Eric M., Deshpande, Chinmay, Shao, Qiujun (Samantha)
Zdroj: In Multiple Sclerosis and Related Disorders July 2023
Databáze: ScienceDirect